Evonik opens R&D facility for life sciences in Greater Boston area
R&D

Evonik opens R&D facility for life sciences in Greater Boston area

New Evonik Creavis’ Innovation Satellite in Cambridge, Mass., will focus on healthcare innovations

  • By ICN Bureau | June 30, 2024

Creavis, Evonik’s strategic innovation unit and business incubator, has opened an Innovation Satellite with labs and offices in Cambridge, Mass., in the Greater Boston metropolitan area.

The activities will initially focus on research and development for healthcare innovations like nucleic acid-based medicines. Evonik’s Venture Capital activities in the healthcare sector will benefit from the presence in North America’s life sciences cluster.

“With our new Innovation Satellite in Cambridge, we are extending an invitation for collaboration to the brilliant minds across this dynamic region,” says Anil Saxena, the head of the Innovation Satellite who also leads Evonik’s Research, Development & Innovation (RD&I) in the North America region. “We look forward to weaving our capabilities into the local life sciences ecosystem and advancing the industry‘s growth,” adds Christian Kessler, head of Creavis’ life sciences unit.

The Greater Boston area is one of the world’s largest biotech hubs with more than 1,000 biotechnology companies ranging from small startups to established pharma giants ─ due to an unparalleled ecosystem of world-class academic institutions like MIT (Massachusetts Institute of Technology), venture capital firms, and a collaborative environment. Evonik is a long-time member of the MIT Industrial Liaison Program, which is dedicated to creating long-term strategic relationships between the university and large corporations worldwide.

"Addressing the global challenges of our time requires the worldwide collaboration of competent partners, and we are looking forward to jointly developing innovative solutions. We are strengthening regional R&D in North America and Asia to benefit from innovative ideas outside of Europe and be closer to our customers in those regions," says Ralph Marquardt, the Chief Innovation Officer of the Germany-based specialty chemicals company.

“North America has become a crucial growth region for Evonik,” adds Guido Skudlarek, Evonik’s President North America. “The Cambridge Innovation Satellite will contribute to the next phase of our expansion in the United States, Canada, and Mexico.”

Register Now to Attend Navigating the Path to Net-zero in the Chemicals Industry on Friday, 26 July 2024

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization